Protagonist Therapeutics Inc (PTGX)

A re-review of the PTG-100 results undid the bad news of a discontinuation of Protagonist's clinical study. If the FDA allows the company to run Phase 2/3 studies for PTG-100, then the stock will continue its bounce higher.

Western Refining, Inc. (WNR) Signet Jewelers Ltd. (SIG) Leads 16 Activist Investor Filings

By Fintel Jun 2, 2017

13D and 13G filings are windows into activist investor activity. Today we focus on Western Digital and 15 other filings

Why Shares of Protagonist Therapeutics Rose This Week

From The Motley Fool Apr 21, 2023

The company's lead pipeline candidate is making news.

Protagonist Therapeutics prices $100M offering (NASDAQ:PTGX)

From Seeking Alpha Apr 5, 2023

Protagonist Therapeutics (PTGX) prices its public offering of 5M shares at a public offering price of $20.00 per share.Gross proceeds are expected to be $100M.Underwriters a 30-day...

(NASDAQ:PTGX)

From Seeking Alpha Mar 15, 2023

Protagonist press release (PTGX): Q4 GAAP EPS of -$0.69 misses by $0.10. Cash, cash equivalents and marketable securities as of December 31, 2022 were $237.4 million. R&D expenses...

Hot Stocks: BB, THO drop on earnings news; SQSP rallies; PTGX surges on clinical data

From Seeking Alpha Mar 7, 2023

BB and THO dropped on earnings news. SQSP rallied after the release of its quarterly update. PTGX jumped on clinical data.

Johnson & Johnson, Protagonist win mid-stage plaque psoriasis trial (NASDAQ:PTGX)

From Seeking Alpha Mar 7, 2023

Protagonist Therapeutics (PTGX) announced Tuesday that plaque psoriasis candidate JNJ-2113, developed with Johnson & Johnson succeeded in a Phase 2 trial. Read the full story here.

Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Polynovo Limited (OtherCALZF)

From TipRanks Dec 7, 2022

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Protagonist Therapeutics (PTGX – Research Report) an...

Protagonist Therapeutics Inc (PTGX)

3 Biotech Stocks to Buy Before They Boom

7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

3 Desirable Drug Stocks With Very Promising Pipelines

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Protagonist Therapeutics Inc (PTGX)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

PTGX Stock Predictions, Articles, and Protagonist Therapeutics Inc News

Subscriber Sign in